- Home
- ELAN vs ADMA Comparison
ELAN vs ADMA Comparison
Compare ELAN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAN
- ADMA
- Stock Information
- Founded
- ELAN 1954
- ADMA 2004
- Country
- ELAN United States
- ADMA United States
- Employees
- ELAN N/A
- ADMA N/A
- Industry
- ELAN Biotechnology: Pharmaceutical Preparations
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELAN Health Care
- ADMA Health Care
- Exchange
- ELAN Nasdaq
- ADMA Nasdaq
- Market Cap
- ELAN 6.0B
- ADMA 5.1B
- IPO Year
- ELAN 2018
- ADMA N/A
- Fundamental
- Price
- ELAN $13.48
- ADMA $17.74
- Analyst Decision
- ELAN Buy
- ADMA Strong Buy
- Analyst Count
- ELAN 6
- ADMA 4
- Target Price
- ELAN $15.17
- ADMA $24.25
- AVG Volume (30 Days)
- ELAN 5.8M
- ADMA 2.7M
- Earning Date
- ELAN 08-07-2025
- ADMA 08-07-2025
- Dividend Yield
- ELAN N/A
- ADMA N/A
- EPS Growth
- ELAN N/A
- ADMA N/A
- EPS
- ELAN 0.75
- ADMA 0.84
- Revenue
- ELAN $4,427,000,000.00
- ADMA $459,381,000.00
- Revenue This Year
- ELAN $4.28
- ADMA $23.35
- Revenue Next Year
- ELAN $4.67
- ADMA $27.67
- P/E Ratio
- ELAN $17.93
- ADMA $21.27
- Revenue Growth
- ELAN 1.42
- ADMA 62.23
- 52 Week Low
- ELAN $8.02
- ADMA $10.21
- 52 Week High
- ELAN $18.55
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- ELAN 56.01
- ADMA 32.83
- Support Level
- ELAN $13.32
- ADMA $20.42
- Resistance Level
- ELAN $14.15
- ADMA $22.37
- Average True Range (ATR)
- ELAN 0.38
- ADMA 0.88
- MACD
- ELAN -0.16
- ADMA -0.28
- Stochastic Oscillator
- ELAN 27.11
- ADMA 1.07
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.